CURRENT
ISSUE1634
October 4, 2021
Annual vaccination against influenza A and B viruses
is recommended for everyone ≥6 months old without a
contraindication.1 Available influenza vaccines for the
2021-2022 season are listed in Table 2. read more...
More from issue 1634
- Azstarys (Serdexmethylphenidate/Dexmethylphenidate) for ADHD
- In Brief: Semglee - Insulin Glargine Interchangeable with Lantus
- In Brief: New Warnings for Janus Kinase Inhibitors
- Leuprolide Acetate (Fensolvi) for Central Precocious Puberty (online only)
- Belimumab (Benlysta) for Lupus Nephritis (online only)
Advance Release
Coming Soon
Treatment of Onychomycosis
Bamlanivimab and Etesevimab for Post-Exposure Prophylaxis of COVID-19
Trilaciclib (Cosela) to Prevent Myelosuppression in Small Cell Lung Cancer
Recommend to Your Library
Previous Issues
September 20, 2021 (1633)
- In Brief: Third Dose of mRNA-based COVID-19 Vaccines for Immunocompromised Persons
- Anifrolumab (Saphnelo) for Systemic Lupus Erythematosus
- Ozanimod (Zeposia) for Ulcerative Colitis
- In Brief: Higher-Dose Naloxone Nasal Spray (Kloxxado) for Opioid Overdose
September 6, 2021 (1632)
- Treatment of Clostridioides difficile Infection
- Ibrexafungerp (Brexafemme) for Vulvovaginal Candidiasis
- Rilonacept (Arcalyst) for Recurrent Pericarditis
August 23, 2021 (1631)
- In Brief: Shingrix for Immunocompromised Adults
- Casirivimab and Imdevimab (REGEN-COV) for Post-Exposure Prophylaxis of COVID-19
- Finerenone (Kerendia) for Chronic Kidney Disease
- Dasiglucagon (Zegalogue) for Severe Hypoglycemia
- Voclosporin (Lupkynis) for Lupus Nephritis
- In Brief: Oritavancin (Kimyrsa) for Skin and Skin Structure Infections (online only)
- In Brief: A Shorter Treatment Regimen for Tuberculosis (online only)
August 9, 2021 (1630)
- In Brief: Guillain-Barré Syndrome with the Johnson & Johnson COVID-19 Vaccine
- Myfembree for Fibroid-Associated Heavy Menstrual Bleeding
- Ponesimod (Ponvory) for Multiple Sclerosis
- Fenfluramine (Fintepla) for Dravet Syndrome
July 26, 2021 (1629)
- An EUA for Tocilizumab (Actemra) for COVID-19
- In Brief: Dapagliflozin (Farxiga) for Chronic Kidney Disease
- Sunscreens
- Addendum: Aducanumab (Aduhelm) for Alzheimer's Disease
- In Brief: Risdiplam (Evrysdi) for Spinal Muscular Atrophy (online only)
- Setmelanotide (Imcivree) for Rare Genetic Forms of Obesity (online only)
- Yutiq - Another Fluocinolone Intravitreal Implant for Uveitis (online only)
